Back to Directory Terence Fenton Email fenton@sdac.harvard.edu Phone 617-632-2009 Institution Statistical & Data Analysis Center Title Principal Research Scientist, Director IMPAACT SDMC Request an Update Affiliated Studies P1020A: A Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and Experienced HIV-infected Infants, Children and Adolescents DAIDS Number 10037 Research Area Treatment Study Status Concluded P1073: Study of Immune Reconstitution Inflammatory Syndrome (IRIS) for International Sites Initiating Highly Active Antiretroviral Therapy (HAART) in Infants and Children <72 Months of Age DAIDS Number 10655 Research Area Other Study Status Concluded 1077FF: PROMISE 1077FF DAIDS Number 10778 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed P1002s: Intensive PK substudy of saquinavir and nelfinavir DAIDS Number 10312 Research Area Other Study Status Concluded P1024: Evaluation of the Immunogenicity of Pneumococcal Conjugate Vaccine DAIDS Number 10269 Research Area Other Study Status Concluded Show All
P1020A: A Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and Experienced HIV-infected Infants, Children and Adolescents DAIDS Number 10037 Research Area Treatment Study Status Concluded
P1073: Study of Immune Reconstitution Inflammatory Syndrome (IRIS) for International Sites Initiating Highly Active Antiretroviral Therapy (HAART) in Infants and Children <72 Months of Age DAIDS Number 10655 Research Area Other Study Status Concluded
1077FF: PROMISE 1077FF DAIDS Number 10778 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed
P1002s: Intensive PK substudy of saquinavir and nelfinavir DAIDS Number 10312 Research Area Other Study Status Concluded
P1024: Evaluation of the Immunogenicity of Pneumococcal Conjugate Vaccine DAIDS Number 10269 Research Area Other Study Status Concluded